Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 574,132 |
|
|||||
| News | - | ||||||
| Day High | 110.50 | Low High |
|||||
| Day Low | 108.205 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Jazz Pharmaceuticals PLC | JAZZ | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -1.50 | -1.36% | 108.99 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 110.13 | 108.205 | 110.50 | 108.99 | 110.49 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13,604 | 574,132 | $ 108.81 | $ 62,473,651 | - | 103.01 - 146.70 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:11:58 | 1 | $ 108.20 | USD |
Jazz Pharmaceuticals (JAZZ) Options Flow Summary
Jazz Pharmaceuticals PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 6.79B | 62.35M | - | 3.83B | 414.83M | 6.65 | 16.37 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Jazz Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JAZZ Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 113.15 | 113.96 | 108.205 | 110.91 | 631,024 | -4.16 | -3.68% |
| 1 Month | 109.27 | 113.96 | 103.01 | 110.38 | 652,810 | -0.28 | -0.26% |
| 3 Months | 128.88 | 134.17 | 103.01 | 116.05 | 679,555 | -19.89 | -15.43% |
| 6 Months | 122.43 | 134.17 | 103.01 | 118.76 | 627,249 | -13.44 | -10.98% |
| 1 Year | 131.22 | 146.70 | 103.01 | 124.36 | 616,179 | -22.23 | -16.94% |
| 3 Years | 180.00 | 189.00 | 103.01 | 139.82 | 587,313 | -71.01 | -39.45% |
| 5 Years | 138.70 | 189.00 | 86.88 | 138.69 | 595,726 | -29.71 | -21.42% |
Jazz Pharmaceuticals Description
| Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy. |
